Logo image of SNWV

SANUWAVE HEALTH INC (SNWV) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:SNWV - US80303D3052 - Common Stock

26.59 USD
-0.76 (-2.78%)
Last: 1/23/2026, 8:00:02 PM
26.59 USD
0 (0%)
After Hours: 1/23/2026, 8:00:02 PM

SNWV Key Statistics, Chart & Performance

Key Statistics
Market Cap228.14M
Revenue(TTM)41.28M
Net Income(TTM)-7.04M
Shares8.58M
Float8.46M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.93
PEN/A
Fwd PE27.88
Earnings (Next)03-19
IPO2008-11-07
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
SNWV short term performance overview.The bars show the price performance of SNWV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

SNWV long term performance overview.The bars show the price performance of SNWV in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of SNWV is 26.59 USD. In the past month the price decreased by -12.13%.

SANUWAVE HEALTH INC / SNWV Daily stock chart

SNWV Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SNWV Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SNWV. SNWV may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SNWV Financial Highlights

Over the last trailing twelve months SNWV reported a non-GAAP Earnings per Share(EPS) of -0.93. The EPS decreased by -830.5% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -19.79%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%117.4%
Sales Q2Q%22.34%
EPS 1Y (TTM)-830.5%
Revenue 1Y (TTM)40.89%

SNWV Forecast & Estimates

8 analysts have analysed SNWV and the average price target is 55.08 USD. This implies a price increase of 107.15% is expected in the next year compared to the current price of 26.59.

For the next year, analysts expect an EPS growth of 106.17% and a revenue growth 38.08% for SNWV


Analysts
Analysts82.5
Price Target55.08 (107.15%)
EPS Next Y106.17%
Revenue Next Year38.08%

SNWV Ownership

Ownership
Inst Owners50.42%
Ins Owners1.33%
Short Float %5.05%
Short Ratio5.41

About SNWV

Company Profile

SNWV logo image SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Eden Prairie, Minnesota and currently employs 46 full-time employees. The company went IPO on 2008-11-07. The company is a provider of wound care products. The company is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.

Company Info

SANUWAVE HEALTH INC

9600 W. 6Th Sstreet

Eden Prairie MINNESOTA US

Employees: 46

SNWV Company Website

SNWV Investor Relations

Phone: 19526561029

SANUWAVE HEALTH INC / SNWV FAQ

Can you describe the business of SANUWAVE HEALTH INC?

SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Eden Prairie, Minnesota and currently employs 46 full-time employees. The company went IPO on 2008-11-07. The company is a provider of wound care products. The company is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.


Can you provide the latest stock price for SANUWAVE HEALTH INC?

The current stock price of SNWV is 26.59 USD. The price decreased by -2.78% in the last trading session.


Does SNWV stock pay dividends?

SNWV does not pay a dividend.


What is the ChartMill rating of SANUWAVE HEALTH INC stock?

SNWV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the Price/Earnings (PE) ratio of SANUWAVE HEALTH INC (SNWV)?

SANUWAVE HEALTH INC (SNWV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.93).


Is SANUWAVE HEALTH INC (SNWV) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SNWV.


What is the Short Interest ratio of SANUWAVE HEALTH INC (SNWV) stock?

The outstanding short interest for SANUWAVE HEALTH INC (SNWV) is 5.05% of its float.